wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q42847992-25FBDB5D-45BB-46A7-9B66-264EEC3230CE
Q42847992-25FBDB5D-45BB-46A7-9B66-264EEC3230CE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42847992-25FBDB5D-45BB-46A7-9B66-264EEC3230CE
Trial Watch: Anticancer radioimmunotherapy.
P2860
Q42847992-25FBDB5D-45BB-46A7-9B66-264EEC3230CE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42847992-25FBDB5D-45BB-46A7-9B66-264EEC3230CE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5b263fa6a5991fe1f1f4225a76d642d675b70597
P2860
Cells at intermediate oxygen levels can be more important than the "hypoxic fraction" in determining tumor response to fractionated radiotherapy.